Universal Health Services, Inc. provided earnings guidance for the year ending December 31, 2024. For the period, the company's net revenues are estimated to be approximately $15.411 billion to $15.706 billion representing an increase of 7.9% to 10.0% over 2023 net revenues of $14.282 billion. EPS-diluted range is estimated to be $13.00 per diluted share to $14.00 per diluted share.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
184.5 USD | -1.14% | +5.80% | +22.41% |
May. 31 | Goldman Sachs Adjusts Price Target on Universal Health Services to $200 From $189 | MT |
May. 30 | JPMorgan Adjusts Price Target on Universal Health Services to $186 From $182 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.41% | 12.49B | |
+22.91% | 87.14B | |
-23.75% | 75.59B | |
+1.76% | 26.78B | |
+4.49% | 17.89B | |
-14.20% | 16.44B | |
+2.34% | 15.68B | |
+72.91% | 13.3B | |
+76.91% | 13.06B | |
+3.42% | 12.54B |
- Stock Market
- Equities
- UHS Stock
- News Universal Health Services, Inc.
- Universal Health Services, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024